(Q48273509)

10 February 2018

title

Hyperglycemia during ischemia rapidly accelerates brain damage in stroke patients treated with tPA. (English)

1 reference

10 February 2018

1 reference

1

1 reference

10 February 2018

José Alvarez-Sabín

8

1 reference

10 February 2018

Josep Munuera

Josep Munuera

Marta A Rubiera Del Fueyo

7

0 references

4

Marta Rubiera

1 reference

10 February 2018

Alex Rovira

6

Alex Rovira

1 reference

10 February 2018

Raquel Delgado-Mederos

5

Raquel Delgado-Mederos

1 reference

10 February 2018

author name string

Carlos A Molina

2

1 reference

10 February 2018

Pilar Delgado

3

1 reference

10 February 2018

publication date

14 February 2007

1 reference

10 February 2018

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

10 February 2018

volume

27

1 reference

10 February 2018

issue

9

1 reference

10 February 2018

page(s)

1616-1622

1 reference

10 February 2018

Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Prediction of early neurological deterioration using diffusion- and perfusion-weighted imaging in hyperacute middle cerebral artery ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Transcranial doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Stroke topography and outcome in relation to hyperglycaemia and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Influence of hyperglycaemia on infarct size and clinical outcome of acute ischemic stroke patients with intracranial arterial occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Intensive insulin therapy in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Hyperglycemic versus normoglycemic stroke: topography of brain metabolites, intracellular pH, and infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Combining insulin-like growth factor derivatives plus caffeinol produces robust neuroprotection after stroke in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Intraventricular administration of insulin and IGF-1 in transient forebrain ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

Hyperglycemia and early reperfusion therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

7 January 2021

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

7 January 2021

Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

7 January 2021

Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

7 January 2021

Number Needed to Treat Estimates Incorporating Effects Over the Entire Range of Clinical Outcomes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

7 January 2021

Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

7 January 2021

Hyperglycemia in the acute phase of stroke is not caused by stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600460

7 January 2021

Identifiers

DOI

10.1038/SJ.JCBFM.9600460

1 reference

10 February 2018

PubMed ID

17299452

1 reference

10 February 2018